186 related articles for article (PubMed ID: 35625334)
21. Pharmacists' perception of their challenges at work, focusing on antimicrobial resistance: a qualitative study from Bangladesh.
Darj E; Newaz MS; Zaman MH
Glob Health Action; 2019; 12(sup1):1735126. PubMed ID: 32131711
[No Abstract] [Full Text] [Related]
22. Strengthening multisectoral coordination on antimicrobial resistance: a landscape analysis of efforts in 11 countries.
Joshi MP; Hafner T; Twesigye G; Ndiaye A; Kiggundu R; Mekonnen N; Kusu N; Berthé S; Lusaya EP; Acho A; Tuala RT; Siddiqua A; Kaboré H; Aidara SS; Guzman J
J Pharm Policy Pract; 2021 Feb; 14(1):27. PubMed ID: 33648589
[TBL] [Abstract][Full Text] [Related]
23. National action plan of the Islamic Republic of Iran for combating antimicrobial resistance during 2016 - 2021.
Moradi G; Gouya MM; Eshrati B; Mohraz M; Piroozi B
Med J Islam Repub Iran; 2018; 32():65. PubMed ID: 30643740
[No Abstract] [Full Text] [Related]
24. The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans.
Munkholm L; Rubin O
Global Health; 2020 Nov; 16(1):109. PubMed ID: 33176810
[TBL] [Abstract][Full Text] [Related]
25. Understanding the Implementation of Antimicrobial Policies: Lessons from the Hong Kong Strategy and Action Plan.
Song M; Deng Z; Chan O; Grépin KA
Antibiotics (Basel); 2022 May; 11(5):. PubMed ID: 35625280
[TBL] [Abstract][Full Text] [Related]
26. India's National Action Plan on Antimicrobial Resistance: a critical perspective.
Nair M; Zeegers MP; Varghese GM; Burza S
J Glob Antimicrob Resist; 2021 Dec; 27():236-238. PubMed ID: 34695609
[TBL] [Abstract][Full Text] [Related]
27. One Health Surveillance of Antimicrobial Use and Resistance: Challenges and Successes of Implementing Surveillance Programs in Sri Lanka.
Ariyawansa S; Gunawardana KN; Hapudeniya MM; Manelgamage NJ; Karunarathne CR; Madalagama RP; Ubeyratne KH; Wickramasinghe D; Tun HM; Wu P; Lam TTY; Chan OSK
Antibiotics (Basel); 2023 Feb; 12(3):. PubMed ID: 36978313
[TBL] [Abstract][Full Text] [Related]
28. National action plan of the Islamic Republic of Iran for combating antimicrobial resistance during 2016 - 2021.
Moradi G; Gouya MM; Eshrati B; Mohraz M; Molaei L; Piroozi B
Med J Islam Repub Iran; 2018; 32():82. PubMed ID: 30643757
[No Abstract] [Full Text] [Related]
29. Tracking progress on antimicrobial resistance by the quadripartite country self-assessment survey (TrACSS) in G7 countries, 2017-2023: opportunities and gaps.
Sabbatucci M; Ashiru-Oredope D; Barbier L; Bohin E; Bou-Antoun S; Brown C; Clarici A; Fuentes C; Goto T; Maraglino F; Morin J; Rönnefahrt I; Sanwidi A; Triggs-Hodge C; Vitiello A; Zovi A; Gelormini M; Lo Fo Wong D
Pharmacol Res; 2024 Jun; 204():107188. PubMed ID: 38705262
[TBL] [Abstract][Full Text] [Related]
30. Public perception and community-level impact of national action plans on antimicrobial resistance in Vietnam.
Thomas SA; Mathew P; Ranjalkar J; Nguyen TBV; Giao VTQ; Chandy SJ
JAC Antimicrob Resist; 2024 Feb; 6(1):dlad146. PubMed ID: 38161968
[TBL] [Abstract][Full Text] [Related]
31. A Qualitative Study on the Policy Process and Development of the National Action Plan on Antimicrobial Resistance in Singapore.
Chua AQ; Verma M; Azupardo K; Lota MM; Hsu LY; Legido-Quigley H
Antibiotics (Basel); 2023 Aug; 12(8):. PubMed ID: 37627742
[TBL] [Abstract][Full Text] [Related]
32. Drug Inspector as an antibiotic Steward: challenges and recommendations to implement national action plan of Pakistan on antimicrobial resistance.
Bajwa M; Afzal S; Sheikh SA; Saleem Z
Expert Rev Anti Infect Ther; 2024 Jun; ():. PubMed ID: 38872588
[TBL] [Abstract][Full Text] [Related]
33. Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries.
Harant A
Antimicrob Resist Infect Control; 2022 Jan; 11(1):15. PubMed ID: 35073967
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial resistance in China across human, animal, and environment sectors - a review of policy documents using a governance framework.
Yang D; Dyar OJ; Yin J; Ma W; Sun Q; Lundborg CS
Lancet Reg Health West Pac; 2024 Jul; 48():101111. PubMed ID: 38948912
[TBL] [Abstract][Full Text] [Related]
35. Control of antimicrobial resistance in Cameroon: Feasibility of implementing the National Action Plan.
Amin ET; Omeichu AA; Shu DM; Ekome SRE; Njumkeng C; van der Sande MAB
Trop Med Int Health; 2021 Oct; 26(10):1231-1239. PubMed ID: 34218501
[TBL] [Abstract][Full Text] [Related]
36. Unpacking multi-level governance of antimicrobial resistance policies: the case of Guangdong, China.
Chan OSK; Wernli D; Liu P; Tun HM; Fukuda K; Lam W; Xiao Y; Zhou X; Grépin KA
Health Policy Plan; 2022 Oct; 37(9):1148-1157. PubMed ID: 35775460
[TBL] [Abstract][Full Text] [Related]
37. Pathways of antibiotic use in Bangladesh: qualitative protocol for the PAUSE study.
Rousham EK; Islam MA; Nahar P; Lucas PJ; Naher N; Ahmed SM; Nizame FA; Unicomb L
BMJ Open; 2019 Jan; 9(1):e028215. PubMed ID: 30782763
[TBL] [Abstract][Full Text] [Related]
38. Raising awareness of antimicrobial resistance in rural aquaculture practice in Bangladesh through digital communications: a pilot study.
Thornber K; Huso D; Rahman MM; Biswas H; Rahman MH; Brum E; Tyler CR
Glob Health Action; 2019; 12(sup1):1734735. PubMed ID: 32153258
[TBL] [Abstract][Full Text] [Related]
39. Evaluating Integrated Surveillance for Antimicrobial Use and Resistance in England: A Qualitative Study.
Bennani H; Cornelsen L; Stärk KDC; Häsler B
Front Vet Sci; 2021; 8():743857. PubMed ID: 34805336
[TBL] [Abstract][Full Text] [Related]
40. Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data.
Nabadda S; Kakooza F; Kiggundu R; Walwema R; Bazira J; Mayito J; Mugerwa I; Sekamatte M; Kambugu A; Lamorde M; Kajumbula H; Mwebasa H
JMIR Public Health Surveill; 2021 Oct; 7(10):e29954. PubMed ID: 34673531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
